Currently, the commonly used endocrine therapy drugs for treating breast cancer include selective estrogen receptor modulators (SERMs), selective estrogen receptor down-regulators (SERDs), and aromatase inhibitors (AIs). The gene discussed is ESR1; the disease is breast carcinoma.